NFL Cannabis Policy 2026: 350 ng/mL Threshold, $15K-$20K Fines

Status: Tested, but Fines Only Tested, fines only

Pre-2020, the NFL was the most punitive of the major U.S. leagues on cannabis. The substance-abuse policy created stigmatized "stages" with escalating discipline; the urinary THC-COOH threshold sat at 15 ng/mL until 2014 and 35 ng/mL from 2014 to 2020. Star players whose careers were defined by that framework include Ricky Williams (multiple suspensions, missing the 2004 and 2006 seasons), Josh Gordon (repeated multi-year suspensions that effectively halted his prime), and post-career advocates including Randy Moss, Calvin Johnson, Eugene Monroe, Marvin Washington, and Kyle Turley. Tyrann Mathieu was dismissed from LSU on August 10, 2012 after multiple failed tests; he later told Fox 8 New Orleans (Jan 29, 2026): "I believe getting kicked out of LSU was the reason I had a 12-year career." See Williams & Gordon for the case throughline that drove reform.

Threshold History: 15 → 35 → 150 → 350

The NFL's threshold has tracked the rest of the sports world's grudging accommodation of out-of-competition use:

• Pre-2014 — 15 ng/mL (the same level WADA used until May 2013).
• 2014–2020 — 35 ng/mL.
• March 2020 — 150 ng/mL, aligned with WADA's post-2013 standard.
• December 6, 2024 — 350 ng/mL, the highest threshold of any major U.S. sports body.

For the metabolite math behind these thresholds, see THC-COOH Thresholds & Windows.

The March 2020 CBA: Suspensions End

The 2020 NFL-NFLPA CBA (effective March 2020) ended suspensions for positive cannabis tests, raised the threshold to 150 ng/mL, and narrowed testing to roughly the two-week window from start of training camp to first preseason game. Out-of-camp cannabis use stopped triggering tests entirely. The carve-out reflected the scale of pre-2020 enforcement — the league had spent two decades suspending players over a substance with no demonstrated performance-enhancing effect (see THC and Performance).

The December 6, 2024 Modification: $15K–$20K Fines

The December 6, 2024 NFL-NFLPA modification, first reported by ESPN's Adam Schefter and the Associated Press, raised the THC threshold from 150 to 350 ng/mL and replaced game-check fines with fixed-dollar fines: $15,000 for a first offense and $20,000 for a second. The structural shift — from variable game-check loss to fixed dollar fines — matters because it decouples the financial penalty from the player's salary, removing the disproportionate hit on lower-paid players that the prior scheme produced. The change was reported by NFL.com, ESPN, and Marijuana Moment.

The Joint Pain Management Committee

The 2020 CBA created the Joint Pain Management Committee (PMC), co-chaired by Dr. Kevin Hill (Director of Addiction Psychiatry at Beth Israel Deaconess, Associate Professor at Harvard Medical School) and on the NFLPA side by Dr. Thom Mayer. The PMC issued a 2021 RFP that drew 106 submissions. On February 1, 2022, the NFL announced $1 million in awards split between two teams:

• UC San Diego's Center for Medicinal Cannabis Research — Dr. Mark Wallace and Dr. Thomas Marcotte, co-PIs — studying vaporized 4% THC, 12% CBD, combined THC/CBD, and placebo for "relief of post-competition soft-tissue injury pain in elite athletes" (using rugby-player participants, given NFL CBA constraints on active-player THC research).
• University of Regina — Dr. Patrick Neary — studying cannabinoids for concussion neuroprotection.

A second round announced in 2023 funded the Atlantic Spine & Pain Network (CBD plus non-invasive vagal-nerve stimulation for concussion) and Emory University (mindfulness-based interventions). ⚠️ Emerging The PMC research is ongoing — results are not yet sufficient to inform NFL clinical guidance.

The NFL Athlete-Entrepreneur Ecosystem

While the league still tests, the NFL alumni network has built one of pro sports' deepest cannabis-business benches:

• Calvin Johnson and Rob Sims co-founded Primitiv Group in Niles, Michigan in 2021. The company partnered with the Harvard International Phytomedicines and Medical Cannabis Institute (Professor Wilfred Ngwa) to study cannabis applications for chronic pain and chronic traumatic encephalopathy (CTE). See Calvin Johnson & Primitiv.
• Ricky Williams — Real Wellness (2018) and Highsman (2021).
• Marshawn Lynch — Dodi Blunts.
• Marvin Washington — founding member of Athletes for CARE; affiliated with Isodiol.
• Kyle Turley — Neuro XPF.

Eugene Monroe's May 23, 2016 op-ed in The Players' Tribune, "Getting Off the T Train," was the first by an active NFL player to publicly call for the league to remove cannabis from testing and address its opioid dependence. Monroe wrote that "the NFL relies heavily on opioids to get players back on the field as soon as possible, but studies have shown medical marijuana to be a much better solution; it is safer, less addictive and can even reduce opioid dependence." See the full op-ed context at Eugene Monroe Op-Ed.

Active-Player Cases Under the New Framework

Reported THC fines and cases under the post-2020 framework include DeAndre Hopkins, Marquise "Hollywood" Brown, and Ja'Marr Chase. A 2024 discrimination lawsuit by ex-Broncos lineman Eyioma Uwazurike challenged fines arising from a synthetic-cannabinoid prescription — illustrating that the league's PES policy still has live edges, particularly on synthetic cannabinoids and prescription-vs-recreational classification.